Foxm1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. The FOXM1 transcription factor has gained increasing attention in recent years due to its dual roles in both cellular proliferation and post-mitotic neuron survival, making it a unique and complex regulator in the context of neurodegeneration [@supsup2021].
<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>FOXM1 (Forkhead Box M1)</td></tr>
<tr><th>Gene</th><td>FOXM1</td></tr>
<tr><th>UniProt ID</th><td>Q08050</td></tr>
<tr><th>PDB ID</th><td>3G73, 5DJ5</td></tr>
<tr><th>Molecular Weight</th><td>84 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Nucleus</td></tr>
<tr><th>Protein Family</th><td>Fox transcription factor family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">161 edges</a></td>
</tr>
</table>
</div>
Foxm1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. The FOXM1 transcription factor has gained increasing attention in recent years due to its dual roles in both cellular proliferation and post-mitotic neuron survival, making it a unique and complex regulator in the context of neurodegeneration [@supsup2021].
<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>FOXM1 (Forkhead Box M1)</td></tr>
<tr><th>Gene</th><td>FOXM1</td></tr>
<tr><th>UniProt ID</th><td>Q08050</td></tr>
<tr><th>PDB ID</th><td>3G73, 5DJ5</td></tr>
<tr><th>Molecular Weight</th><td>84 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Nucleus</td></tr>
<tr><th>Protein Family</th><td>Fox transcription factor family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">161 edges</a></td>
</tr>
</table>
</div>
FOXM1 (Forkhead Box M1) is a member of the Fox family of transcription factors, characterized by a conserved winged-helix DNA-binding domain. Originally identified as a key regulator of cell cycle progression, FOXM1 has emerged as a critical player in DNA repair, cellular stress responses, and neurodegeneration [@supsup2021]. FOXM1 is expressed in proliferating cells and stem/progenitor cell populations.
FOXM1 contains several functional domains that work together to regulate its activity as a transcription factor [@supsup2022]. The forkhead DNA-binding domain (FH) comprises approximately 100 residues that form the characteristic winged-helix structure responsible for DNA recognition and binding. At the N-terminus, a repressor domain contains the transcriptional inhibition region that suppresses target gene expression. The C-terminal transactivation domain (TAD) is rich in acidic residues and mediates transcriptional activation of downstream genes. The protein also contains multiple phosphorylation sites, including Thr611, Ser715, and Thr724, which are regulated by cyclin/CDK complexes and modulate FOXM1 activity in response to cell cycle signals. Alternative splicing produces distinct isoforms—FOXM1A, FOXM1B, and FOXM1C—each exhibiting different expression patterns and functional properties. The crystal structure (PDB: 3G73) reveals the characteristic three-helix winged-helix fold that is conserved across the Fox transcription factor family [^3].
FOXM1 functions as a master transcriptional regulator that coordinates multiple critical cellular processes essential for cell survival and proliferation.
FOXM1 plays a central role in controlling cell cycle progression by regulating genes required for transition between different phases of the cell cycle. During the G1/S transition, FOXM1 activates expression of Cyclin D1 and E2F1, which are essential for commitment to DNA replication. In S phase, FOXM1 regulates DNA replication factors that ensure proper genome duplication. The G2/M transition is promoted through upregulation of Cyclin B1 and CDC25B, which control entry into mitosis. During M phase, FOXM1 targets include Aurora B kinase, PLK1, and survivin, all of which are required for proper chromosome segregation and cytokinesis [^4].
FOXM1 activates key DNA repair genes across multiple repair pathways to maintain genomic integrity. In nucleotide excision repair, FOXM1 regulates XPA, XPC, and XPD expression, which are essential for recognizing and removing bulky DNA lesions. Homologous recombination repair is supported through activation of BRCA2 and FANCD2, which facilitate error-free repair of double-strand breaks. Base excision repair genes including OGG1 and MUTYH are also under FOXM1 control, enabling repair of oxidized bases and mismatches. Additionally, FOXM1 activates the DNA damage checkpoint genes CHK1 and CHK2, which coordinate cell cycle arrest with DNA repair activities [^5].
Within the nervous system, FOXM1 serves essential functions in maintaining stem cell populations and supporting tissue regeneration. The transcription factor helps maintain the neural stem cell pool throughout life and is required for proper proliferation of progenitor cells during development and adult neurogenesis. These functions position FOXM1 as an important regulator of tissue homeostasis and regenerative capacity.
FOXM1 dysfunction contributes to Alzheimer's disease pathogenesis through multiple interconnected mechanisms that impair neuronal function and survival [^6]. Dysregulation of FOXM1 promotes inappropriate neuronal cell cycle re-entry, a phenomenon where post-mitotic neurons attempt to re-enter the cell cycle, leading to cell death. The impaired FOXM1-mediated DNA repair pathways result in accumulation of DNA damage in neurons over time, contributing to cellular dysfunction. FOXM1 also regulates several tau phosphorylation kinases, linking this transcription factor to tau pathology and neurofibrillary tangle formation. Furthermore, amyloid-β exposure downregulates FOXM1 expression, creating a vicious cycle where Aβ reduces a critical protective factor.
FOXM1 plays a protective role in dopaminergic neurons, and deficiency of this transcription factor causes progressive parkinsonian features in model systems [^7]. The transcription factor supports dopaminergic neuron survival through multiple mechanisms including regulation of mitochondrial function via PGC-1α and mitochondrial biogenesis genes. FOXM1 also activates antioxidant defense genes that protect neurons from oxidative stress, a major contributor to Parkinson's disease pathology. Emerging evidence suggests that FOXM1 may interact with α-synuclein aggregation pathways, potentially influencing the formation of Lewy bodies.
FOXM1 expression is dysregulated in motor neurons exhibiting TDP-43 pathology, a hallmark of ALS. This dysregulation may affect DNA repair capacity in motor neurons, making them more vulnerable to accumulated DNA damage. Altered FOXM1 expression has been observed in both familial and sporadic ALS cases, suggesting a general role in motor neuron degeneration.
FOXM1 target genes are altered in Huntington's disease, contributing to the widespread transcriptional dysfunction observed in this disorder. The resulting impairment of DNA repair pathways may accelerate the accumulation of neuronal DNA damage. These findings suggest that FOXM1 dysfunction represents a common mechanism linking transcriptional disruption to DNA repair deficits in HD.
Thiazole antibiotics such as thiostrepton and siomycin have been identified as FOXM1 inhibitors and are primarily being pursued for cancer therapy applications.
Activation of FOXM1 could potentially enhance DNA repair capacity in neurons undergoing degeneration. Such approaches may protect dopaminergic neurons in Parkinson's disease by bolstering mitochondrial function and oxidative stress responses. FOXM1 activation also shows therapeutic potential in stroke, where enhanced cellular stress responses could limit neuronal damage following ischemia.
The study of Foxm1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.